Massage Chair News: Week of May 11, 2026
The biggest story in the massage chair category this week has nothing to do with a new chair. Luraco, the only U.S.-based manufacturer of medical massage chairs, announced it has achieved Medicare approval, Durable Medical Equipment (DME) licensing, and FDA registration simultaneously, a regulatory milestone that could meaningfully change how buyers with qualifying conditions pay for a high-end chair. On the new-product side, Kyota launched the Konbi M728 DualPro 4D at $7,999, and Human Touch made the Super Novo 3.0 available at $11,999, giving buyers in the upper-mid and premium tiers two new options to evaluate.
New Chairs and Launches
Kyota Konbi M728 DualPro 4D
Kyota announced the Konbi M728 DualPro, a 4D roller model with dual back mechanisms gliding along an L-track from neck to glutes. The chair is now available at $7,999, placing it in the upper-mid Kyota tier alongside the Kenko M673. Standout features include TrueFit body scanning, Zero Wall Fit space-saving recline, an 8-inch touch screen tablet, voice control, an on-board health sensor that reads heart rate and blood oxygen, dual reflexology foot rollers, back and feet heat, and a lumbar cooling option. Twelve auto programs include a full-body stretch sequence. Buyers drawn to Kyota’s build quality and warranty support, which has historically been a strength for the brand, will want to compare this against the Kyota Kenko M673 and a handful of Infinity and Osaki models in the same bracket.
Human Touch Super Novo 3.0
Human Touch confirmed that the Super Novo 3.0, part of its premium Ascent Series, is now available at $11,999. The 3.0 revision signals iterative refinement rather than a ground-up redesign, though Human Touch has not published a detailed spec comparison between the 3.0 and its predecessor. The chair uses the HT Flex S- and L-Track system with a DuoSync dual-quad roller setup that runs both 3D and 4D programs, plus an HT Flex full-body stretch sequence, Rapid Acupoint body sensing, heated foot and calf, and dual-lumbar heat. The Ascent Series positions these chairs as premium wellness products rather than entry-level recliners, with pricing and features to match.
Technology and Innovation
Luraco Earns Medicare Approval, DME Licensing, and FDA Registration
This is the most consequential regulatory development the massage chair category has seen in years. Luraco announced this week that its medical massage chairs are now Medicare-approved, licensed as Durable Medical Equipment, and FDA-registered, three separate and distinct designations that together open a path for qualifying patients to seek insurance reimbursement for a Luraco chair.
What does this mean in practice? DME licensing means a product has met federal standards for therapeutic medical devices, the same designation used for hospital beds, CPAP machines, and mobility aids. FDA registration establishes that the product meets safety and labeling requirements under federal law. Medicare approval means that, for certain qualifying diagnoses, a patient’s insurer may cover part of the cost. None of this guarantees any individual buyer will receive reimbursement, and coverage will depend heavily on diagnosis, insurer, and plan. But for buyers dealing with chronic back conditions, post-surgical recovery, or other documented medical needs, this development is worth a direct conversation with your healthcare provider.
Luraco has positioned itself as the only American manufacturer of medical massage chairs, and this milestone reinforces that distinction. No other brand in the Massage Chair Finder (MCF) review range, including Infinity, Osaki, or Human Touch, holds this combination of designations at this time.
Brand News
Ceragem Secret Garden Limited Edition
Ceragem unveiled a limited-edition massage chair called Secret Garden, created in collaboration with Korean artist Seo Ho-sung. This is a design and aesthetic differentiator aimed at the premium gifting and interior design market rather than a new technology platform. No U.S. availability has been announced.
Worth Reading
Infinity Circadian DualFlex Named International Business Times 2026 Editor’s Pick
The Infinity Circadian DualFlex earned the International Business Times 2026 Editor’s Pick for Best Massage Chair. The Circadian DualFlex is listed at $16,999, putting it at the high end of the Infinity lineup. Its standout feature is a 49-inch Flex-Track that combines L-track coverage with S-track depth for spinal decompression, paired with Syner-D dual back 4D mechanisms, triple foot rollers per foot, Complete Calf kneading and oscillation, and Harman/Kardon premium audio. The IBT recognition is third-party validation worth noting, though awards from media outlets vary considerably in their testing rigor.
What We Are Watching
The Luraco Medicare story will take time to play out in practice, and the most important open question is how real the reimbursement pathway will be for individual buyers. We will be tracking whether any buyers successfully receive insurance coverage under the new DME designation and what diagnosis categories appear most likely to qualify. On the new-product side, the Kyota Konbi M728 DualPro 4D needs verified weight capacity and height range data before we can place it confidently in a buying recommendation. The Human Touch Super Novo 3.0 is available now, and our hands-on review is in progress. Nouhaus also previewed new restorative massage technology at High Point Market in late April without releasing full product details, so a formal announcement from that brand may be coming in the next few weeks. If you are a buyer currently in research mode, this is a good week to let things develop. Use the Chair Finder to clarify your priorities while we confirm specs.
For personalized chair recommendations based on your pain profile and budget, use the Chair Finder.